Outstanding talk given by Shreena K. Gandhi, MD on Social Security Work Disability and Its Predictors in Patients with Fibromyalgia: 25 Years of Followup! 🌟 #ACR2024

An impressive work by @SattuiSEMD on Effectiveness of Interleukin-6 Receptor Inhibitors versus Conventional Synthetic Immunomodulatory Therapy for Treatment of Frail Patients with Polymyalgia Rheumatica. #ACR2024 PittRheum

Outstanding work by Rohit Aggarwal highlighting Treatment Patterns and Glucocorticoid Burden of Dermatomyositis Patients: A Cohort Study in the University of Pittsburgh's Myositis Registry #ACR2024 PittRheum

Meeting a fellow rheumie in person after virtual connections feels like turning shared passion into real-world camaraderie Shreena K. Gandhi, MD #ACR2024 #AWIR

Had an amazing time at #ACR2024! 💜Reconnected with old friends, made new ones, and gained the latest updates in rheumatology. Grateful for the valuable practice pearls as I prepare to enter the field. Can't wait to put them to use! 💡 #rheumtwitter #MedTwitter Priyanjali Pulipati

I am forever grateful for amazing global mentees and colleagues in Myositis. Myositis research feels like fun because of all of you!

Congratulations to our exceptional PGY3 resident, Akanksha Sharma, on successfully matching into the Rheumatology Fellowship at the prestigious Mayo Clinic in Rochester! Wishing you continued success in this next exciting chapter of your journey. #RheumTwitter #rheumatology

Please join Myositis India for a webinar for doctors on management of calcinosis in Myositis. A hard nut to crack ! The Myositis Association Myositis Support and Understanding (MSU)

Does Abatacept work in Myositis! See results of phase 3 RCT on Abatacept efficacy and safety in Myositis. Safe and well tolerated. Efficacy in Necrotizing Myositis and Anti-Synthetase; not in DM. High placebo rates continues to be a problem in trials.

Celebrated our PGY3s on their amazing fellowship matches! Congratulations to all! Nabihah Chaudhary: ID-CCM at UPMC Kanika Aggarwal: Nephrology at Temple Akanksha Sharma: Rheumatology at Mayo Alaa Sayed: Cardiology at UT-Galveston Shehryar Malik: Pulm-CCM at UPMC

Everyone in CTD-ILD world, please see this paper on Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD), a RCT in IIM-ILD. Even though primary outcome was not met, but PFTs and HRCT trends before and after Abatacept are interesting and

I had a wonderful opportunity to present "NXP-2 Positive Myositis Presenting with Oropharyngeal Dysphagia, Skin Rash, and Worsening Raynaud's Phenomenon" at CCR East 2025. It was a valuable experience, with many informative learning sessions throughout the conference. I’m already

Anti-synthetase syndrome (ASyS): Consensus on nomenclature and abbreviation for anti-synthetase syndrome is now done. Everyone should use this nomenclature and abbreviation for the ASyS going forward: an IMACS project academic.oup.com/rheumatology/a…

Thanks to The Journal of Rheumatology for Editor’s choice to our article on CAR-T in Myositis! Watch our full interview by Dr. Earl Silverman from J Rheum

🎓 Congratulations to the Internal Medicine Residency Class of 2025! Your dedication, resilience, and compassion have inspired us all. We’re proud to celebrate your achievements and can’t wait to see the impact you’ll make as physicians. #internalmedicine #residency #graduation

🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫 👄 Oral/Genital Ulcers 🩸 DVT, Arterial Aneurysm 👁️ Uveitis 🧠 Neurologic Involvement 🖐️ Cutaneous / Pathergy #RheumTwitter #Behcets #RheumX